Search research articles
Contact Us
Filters
Showing results (201-210 of 238) with videos related to
Page
of 24
Sort By:
The Lancet Regional Health. Europe
|
June 1, 2023
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
Bang Zheng, Giulia Vivaldi, Luke Daines, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
Maria Jose Lista, Pedro M Matos, Thomas J A Maguire, et al.
The Lancet. Respiratory Medicine
|
May 9, 2021
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, et al.
ERJ Open Research
|
July 16, 2024
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID
Omer Elneima, John R Hurst, Carlos Echevarria, et al.
Nature Communications
|
September 19, 2024
Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in children
Harsita Patel, Michael J Carter, Heather Jackson, et al.
Nature Microbiology
|
October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow, Carl Graham, Blair Merrick, et al.
Intensive Care Medicine
|
April 11, 2018
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Tobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Ebiomedicine
|
February 13, 2022
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
Tom M Quinn, Erin E Gaughan, Annya Bruce, et al.
Nature Medicine
|
June 17, 2022
Redefining critical illness
David M Maslove, Benjamin Tang, Manu Shankar-Hari, et al.
Critical Care (London, England)
|
March 17, 2021
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
Prashant Nasa, Elie Azoulay, Ashish K Khanna, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 238) with videos related to
Sort By:
Page
of 24
The Lancet Regional Health. Europe
|
June 1, 2023
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
Bang Zheng, Giulia Vivaldi, Luke Daines, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
Maria Jose Lista, Pedro M Matos, Thomas J A Maguire, et al.
The Lancet. Respiratory Medicine
|
May 9, 2021
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, et al.
ERJ Open Research
|
July 16, 2024
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID
Omer Elneima, John R Hurst, Carlos Echevarria, et al.
Nature Communications
|
September 19, 2024
Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in children
Harsita Patel, Michael J Carter, Heather Jackson, et al.
Nature Microbiology
|
October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow, Carl Graham, Blair Merrick, et al.
Intensive Care Medicine
|
April 11, 2018
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Tobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Ebiomedicine
|
February 13, 2022
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
Tom M Quinn, Erin E Gaughan, Annya Bruce, et al.
Nature Medicine
|
June 17, 2022
Redefining critical illness
David M Maslove, Benjamin Tang, Manu Shankar-Hari, et al.
Critical Care (London, England)
|
March 17, 2021
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
Prashant Nasa, Elie Azoulay, Ashish K Khanna, et al.
Page
of 24